Express Scripts (ESRX) Guides FY16 EPS Above Expectations
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/22/2026
- S&P 500 is close to flat as investors await technology earnings
- Oil climbs more than 2% to multi-week high as Mideast conflict threatens oil transit routes
- Can Alphabet earnings reignite investor enthusiasm for the Magnificent Seven?
- Foreign buying surge may signal trouble ahead for the S&P 500
- AMD challenges Nvidia with massive Anthropic deal, though shares dip pre-market
- Emirates refusing to take delivery of first 10 Boeing 777X jets
- Intersnack to acquire Utz Brands at $14.25 per share in go-private deal
- Crude Inventory Rose 2 Million Barrels Last Week - EIA
- Wall St ends higher on chip stocks recovery; earnings in focus
- Palo Alto Networks to acquire Embrace to expand observability tools
Express Scripts Holding Company Announces 2016 Financial Guidance and Reaffirms 2015 Financial Guidance
December 22, 2015 7:00 AM ESTST. LOUIS, Dec. 22, 2015 /PRNewswire/ -- Express Scripts Holding Company (Nasdaq: ESRX) anticipates achieving adjusted earnings per diluted share for 2016 in the range of $6.08 to $6.28, representing growth of 10% to 14% over the mid-point of our previously issued 2015 guidance range See table below.
"Our focused model of alignment has positioned us uniquely in the healthcare services landscape to improve health outcomes and lower costs for our clients and patients," said George Paz, CEO and chairman of Express Scripts. "No one matches our focus on serving clients and patients and we remain confident in our... More
